Aptevo Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Aptevo Therapeutics

11/05/2023 20:53

* Aptevo Therapeutics Inc  APVO.OQ  reported quarterly
adjusted
earnings of 39 cents​​ per share for the quarter ended in March.
The mean expectation of two analysts for the quarter was for a
loss of $1.18 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aptevo Therapeutics Inc's reported EPS for the quarter was
39
cents​.
    * The mean earnings estimate of analysts had risen by
about 25.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Aptevo Therapeutics Inc shares had fallen by 15.0% this
quarter and lost 25.4% so far this year.
    * The company reported quarterly net income of $2.77
million.
    * Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $14.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 07:53 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.18          0.39           Beat
 Dec. 31 2022      -1.53          -0.95          Beat
 Sep. 30 2022      -1.64          -1.50          Beat
 Jun. 30 2022      -1.33          5.58           Beat